|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/444 | (2006.01) |
| A61K 31/444 | (2013.01) | ||
| A61K 31/5513 | (2006.01) | ||
| A61K 31/5513 | (2013.01) | ||
| A61K 47/02 | (2013.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 9/28 | (2006.01) | ||
| A61K 47/26 | (2013.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61K 47/38 | (2013.01) | ||
| A61K 47/02 | (2006.01) | ||
| A61K 9/1611 | (2013.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 9/1641 | (2013.01) | ||
| A61K 47/38 | (2006.01) | ||
| A61K 9/1652 | (2013.01) | ||
| A61P 25/30 | (2006.01) | ||
| A61K 9/167 | (2013.01) | ||
| A61K 9/1682 | (2013.01) | ||
| A61K 9/2886 | (2013.01) | ||
| A61K 9/4808 | (2013.01) | ||
| A61P 25/30 | (2018.01) |
| (11) | Number of the document | 3592350 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18764574.2 |
| Date of filing the European patent application | 2018-03-12 | |
| (97) | Date of publication of the European application | 2020-01-15 |
| (45) | Date of publication and mention of the grant of the patent | 2025-03-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/021939 |
| Date | 2018-03-12 |
| (87) | Number | WO 2018/165649 |
| Date | 2018-09-13 |
| (30) | Number | Date | Country code |
| 201762469798 P | 2017-03-10 | US |
| (72) |
STRAUB, Julie , US
DUVVURI, Muralikrishna , US
VED, Parag, M. , US
REHLAENDER, Bruce , US
BREAUX, Jay , US
VADINO, Winston, A. , US
BORAH, Kripanath , US
GLOFF, Carol , US
|
| (73) |
Embera NeuroTherapeutics, Inc. ,
2 Main Street, Building 17
Suite 302P, Biddeford, ME 04005,
US
|
| (54) | PHARMACEUTICAL COMPOSITIONS COMPRISING METYRAPONE AND OXAZEPAM AND USES THEREOF |
| PHARMACEUTICAL COMPOSITIONS COMPRISING METYRAPONE AND OXAZEPAM AND USES THEREOF |